Zoetis Inc. (ZTS)

155.24 -1.24 (-0.79%) At close: 4:05PM EST

Zoetis Inc.

10 Sylvan Way
Parsippany, NJ 07054
United States
973 822 7000
http://www.zoetis.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 11,300

Key Executives

Name	Title	Pay	Exercised	Year Born
Ms. Kristin C. Peck	CEO & Director	1.53M	2.43M	1971
Mr. Glenn C. David	Exec. VP & CFO	1.52M	1.96M	1972
Dr. Catherine A. Knupp	Exec. VP and Pres of R&D	1.51M	3.92M	1961
Ms. Roxanne Lagano	Exec. VP and Chief HR Officer & Global Operations	N/A	N/A	1965
Ms. Wafaa Mamilli	Exec. VP and Chief Information & Digital Officer	N/A	N/A	1967
Mr. Steven Frank	VP of Investor Relations	N/A	N/A	N/A
Ms. Heidi C. Chen	Exec. VP, Gen. Counsel & Corp. Sec.	N/A	N/A	1967
Mr. William Price	VP & Chief Communications Officer	N/A	N/A	N/A
Mr. Roman Trawicki	Exec. VP and Pres of Global Manufacturing & Supply	N/A	N/A	1964
Mr. Timothy J. Bettington	Exec. VP & Pres of U.S. Operations	N/A	N/A	1974

Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms. It also provides other pharmaceutical products, which comprise pain and sedation, antiemetic, reproductive, and oncology products; Dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives that offer medicines to livestock. In addition, the company offers portable blood and urine analysis systems, and point-of-care diagnostic products, including instruments and reagents, rapid immunoassay tests, reference laboratory kits, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision livestock farming. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Corporate Governance

Zoetis Inc.’s ISS Governance QualityScore as of December 2, 2020 is 7. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 9; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.